Macular pigment and age related macular degeneration

British Journal of Ophthalmology

Volumn 83, Issue 7, 1999, Pages 867-877

  Beatty, S ^a   Boulton, M ^a   Henson, D ^a   Koh, H H ^b   Murray, I J ^b  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; CAROTENOID; VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN; ZINC;

CIGARETTE SMOKING; CLINICAL TRIAL; DISEASE CLASSIFICATION; DRUG MECHANISM; EYE COLOR; FILTER; GENDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LENS; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOTOMETRY; PRIORITY JOURNAL; REFLECTOMETRY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; REVIEW; VITAMIN SUPPLEMENTATION;

EID: 0032791567     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.7.867     Document Type: Review

References (152)

1. Snodderly DM, Auran JD, Delori FC. The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 1984;25:674-85.
2. Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vis Res 1985;25:1531-5.
3. Handelman GJ, Dratz EA, Reay CC, et al. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci 1988;29:850-5.
4. Nussbaum JJ, Pruett RC, Delori FC. Macular yellow pigment. The first 200 years. Retina 1981;1:296-310.
5. Reading VM, Weale RA. Macular pigment and chromatic aberration. J Optom Soc Am 1974;64:231-4.
6. Dichtburn RW, Eye movements and visual perception. Oxford: Clarendon Press, 1973.
7. Bone RA, Landrum JT. Macular pigment in Henle fiber membranes: a model for Haidinger's brushes. Vis Res 1984;24:103-8.
8. Kirschfeld K. Carotenoid pigments: their possible role in protecting against photooxidation in eyes and photoreceptor cells. Proc R Soc Lond 1982;216: 71-85.
9. Foote CS, Chang YC, Denny RW. Chemistry of singlet oxygen. X. Carotenoid quenching parallels biological protection. J Am Chem Soc 1970;92: 5216-18.
10. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins- Am J Clin Nutr 1995;62(suppl):1448s-60s.
11. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study Monograph; an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980;24:335-609.
12. Pryor WA. The free radical theory of aging revisited: a critique and a specific disease-specific theory. In: Butler RN, Sprott RL, Schneider EL, eds. Modern biological theories of aging. New York: Raven Press, 1987:42-63.
13. Young RW. Solar radiation and age-related macular degeneration. Surv Ophthalmol 1988;32:252-69.
14. De La Paz MA, Anderson RE. Regional and age-dependent variation in susceptibility of the human retina to lipid peroxidation. Invest Ophthalmol Vis Sci 1992;33:3497-9.
15. Landrum JT, Bone RA, Kilburn MD. The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharm 1997;38: 537-56.
16. Hammond BR Jr, Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 1996;38:1795-801.
17. Schultze M. In: Ueber den gelben Fleck der Retina, seinen Einflussauf normales Sehen und auf auf Farbenblindheit [[On the yellow spot of the retina: its influence on normal vision and on colour blindness]]- Bonn: von Cohen & Sohn, 1866: 1-5 and 15-16.
18. Wald G. Human vision and the spectrum. Science 1945;101:653-8.
19. Wald G. The photochemistry of vision. Doc Ophthalmol 1949;3:94-137.
20. Bone RA, Landrum JT, Hirne GW, Cains A, Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci 1993;34:2033-40.
21. The International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Qphthalmol 1995;39:367-74.
22. Ghafour IM, Allan D, Foulds WS. Common causes of visual handicap in the west of Scotland. Br J Ophthalmol 1983;67:209-13.
23. Klein R, Wang Q, Klein BEK, et al. The relationship of age-related maculopathy, cataract and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182-91.
24. Ferris FL III. Senile macular degeneration: review of epidemiologic features. Am J Epidemiol 1983;118:132-51.
25. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988;32:375-413.
26. Klein BE, Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol 1982;100:571-3.
27. Klein R, Klein BEK, Linton KLP, Prevalence of age-related maculopathy. Ophthalmology 1992;99:933-43.
28. Mitchell P, Smith W, Attebo K, et al. Prevalence of age-related maculopathy in Australia, the Blue Mountains Eye Study. Ophthalmology 1995;102: 1450-60.
29. Klein R, Davis MDD, Magli Y, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98:1128-34.
30. Klein R, Klein BEK, Jensen SC, et al. The Beaver Dam Eye Study. The five-year incidence and progression of age-related maculopathy. Ophthalmology 1997;104:7-22.
31. Snodderly DM, Handelman GJ, Adler AJ. Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci 1991;32:268-79.
32. Hainmond BR Jr., Wooten BR, Snodderly DM. Individual variations in the spatial profile of human macular pigment. J Am Opt Soc Am 1997;14:1187-96.
33. Bone RA, Landrum JT, Fernandez L, et al. Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci 1988;29:843-9.
34. Pease PL, Adams AJ, Nuccio E. Optical density of human macular pigment. Vis Res 1987;27:705-10.
35. Hammond BR Jr, Fuld K. Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci 1992;33:350-5.
36. Werner JS, Donnelly SK, Kliegl R. Aging and human macular pigment density. [[Appended with translations from the work of Max Schultze and Ewald Hering.]] Vis Res 1987;27:257-68.
37. Handelman GJ, Snodderly DM, Krinsky NI, et al. Biological control of primate macular pigment. Biochemical and densitometric studies. Invest Ophthalmol Vis Sci 1991;32:257-67.
38. Weedon BCL. Occurrence. In: Isler O, ed. Carotenoids, Basle: Birkauser, 1971:267-324.
39. Goodwin TW. Distribution of carotenoids. In: Packer L, ed. Methods of enzymology. San Diego: Academic Press, 1992;213:167-72.
40. Malinow MR, Feeney-Burns L, Peterson LH, et al. Diet-related macular anomalies in monkeys . Invest Ophthalmol Vis Sci 1980;19:857-63.
41. Hammond BR Jr, Curran-Cellantano J, Judd S, et al. Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vis Res 1996;36:2001-9.
42. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;24:453-69.
43. Landrum JT, Bone RA, Joa H, et al. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res 1997; 65:57-62.
44. Khachik F, Beecher GR, Goli MB, et al. Separation, identification, and quantification of carotenoids in fruits, vegetables and human plasma by high performance liquid chromotography. Pure Appl Chem 1991;63:71-80.
45. Khachik F, Beecher GR, Goli MB, Lusby WR. Separation and quantification of carotenoids in foods. In: Packer L, ed. Methods in enzymology. San Diego: Academic Press, 1992;213A:347-59.
46. Khachik F, Beecher GR, Goli MB, et al. Separation and identification of carotenoids and their oxidation products in extracts of human plasma. Anal Chem 1992;64:2111-22.
47. Khachik F, Beecher GR, Goli MB, et al. Separation and quantification of carotenoids in human plasma. In: Packer L, ed. Methods in enzymology, San Diego: Academic Press, 1992;213A:205-19.
48. Khachik F, Spangler CJ, Smith JC Jr, et al. Identification, quantification, and relative concentration of carotenoids and their metabolites in human milk and serum. Anal Chem 1997;69:1873-81.
49. Sommerburg O, Keunen JEE, Bird AC, et al. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 1998;82:907-10.
50. Khachik F, Bernstein PS, Garland DL. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 1997;38:1802-11.
51. Verma SP, Philippot JR, Bonnet B, et al. Resonance Raman spectra of betacarotene in native and modified low density lipoprotein, Biochem Biophys Res Comm 1984;122:867-75.
52. Pattersson T, Ernstrom U, Griffiths W, et al. Lutein associated with a transthyretin indicates carotenoid derivation and novel multiplicity of transthyretin ligands. FEBS Lett 1995;365:23-6.
53. Dufour E, Haertle T. Binding of retinoids and β-carotene to β-lactoglobulin: influence of protein modifications. Biochim Biophys Acta 1991;1079:316-20.
54. Hemmi H, Hata M, Takeuchi M. Studies of the carotenoids in the muscle of salmon: V: Combination of astaxanthin and canthaxanthin with bovine serum albumin and egg albumin. Comp Biochem Physiol 1991;99B:609-12.
55. Bernstein PS, Balashaw NA, Tsong ED, et al. Retinal tubulin binds macular carotenoids. Invest Ophthalmol Vis Sci 1997;38:167-75.
56. Nagle BW, Okamoto C, Taggert B, et al. The teieost cone cytoskeleton: localization of actin, microtubules, and intermediate filaments. Invest Ophthalmol Vis Sci 1986;27:689-701.
57. Bone RA, Landrum JT, Cains A. Optical density spectra of the macular pigment in vivo and in vitro- Vis Res 1992;32:105-10.
58. Handelman GJ, Snodderly DM, Krinsky NI, et al. Biological control of primate macular pigment: biochemical and densitometric studies. Invest Ophihalmol Vis Sci 1991;32:257-67.
59. Hammond BR Jr, Fuld K, Curran-Celentano J. Macular pigment density in monozygotic twins. Invest Ophthalmol Vis Sci 1995;36:2531-41.
60. Reading VM, Weale RA. Macular pigment and chromatic aberration. J Optom Soc Am 1974;64:231-8.
61. Mainster MA, Ham WT Jr, Delori FC. Potential retinal hazards. Instrument and environmental light sources. Ophthalmology 1983;90:927-32.
62. Mainster MA. Spectral transmittance of intraocular lenses and retinal damage from intense light sources. Am J Ophthalmol 1978;85:167-172.
63. Ham WT Jr., Mueller HA, Sliney DH. Retinal sensitivity to radiation damage from short wavelength light. Nature 1976;260:153-8.
64. Ruffolo JJ Jr, Ham WT Jr, Mueller HA, et al. Photochemical lesions in the primate retina under conditions of elevated blood oxygen. Invest Ophthalmol Vis Sci 1984;25:893-8.
65. Farber DB, Flannery JG, Lolley RN, et al. Distribution patterns of photoreceptors, protein, and cyclic nucleotides in the human retina. Invest Ophthalmol 1985;26:1558-68.
66. Werner JS, Steele VG. Sensitivity of human foveal color mechanisms throughout the life span. J Opt Soc Am 1988;5:2122-30.
67. Haegerstrom-Portnoy G, Short-wavelength-sensitive-cone sensitivity with aging: a protective role for macular pigment? J Opt Soc Am 1988;5:2140-4.
68. Snodderly DM, Brown PK, Delori FC, et al. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 1984;25:660-73.
69. Ham WT Jr, Mueller HA, Ruffolo JJ Jr. Retinal effects of blue light exposure. In: Ocular effects of non-ionizing radiation. Bellingham, WA: Society of Photo-Optical Instrumentation Engineers, 1980;229:46-50.
70. Lerman S, Borkman R. Spectroscopic evaluation and classification of normal, aging and cataractous lens. Ophthalmic Res 1976;8:335-3.
71. Sperduto RD, Hiller R, Seigel D. Lens opacities and senile maculopathy. Arch Ophthalmol 1981;99:1004-8.
72. Klein R, Klein BE, Jensen SC, et al. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 1998;116:506-13.
73. Halliwell B. Antioxidants and human disease: a general introduction- Nutr Rev 1997;55:S44-9.
74. Ham WT Jr, Mueller HA, Ruffolo JJ Jr, et al. Action spectrum for retinal injury from near-ultraviolet radiation in the aphakic monkey. Am J Ophihalmol 1982;93:299-306.
75. Cogdell RJ, Monger TG, Parson WW. Carotenoid triplet states in reaction centers from Rhodopseudomonas sphaeroides and Rhodospirillum rubrum. Biochem Biophys Acta 1975;408:189-99.
76. Krinsky NI. Carotenoid protection against oxidation. Pure Appl Chem 1979; 51:649-60.
77. Jorgensen K, Skibsted LH. Carotenoid scavenging of radicals. Z Lebensm Unters Forsch 1993;196:423-9.
78. Lim BP, Nagao A, Terao J, er al. Antioxidant activity of xanthophylls on peroxyl radical-mediated phospholipid peroxidation, Biochim Biophys Acta 1992;1126:178-84.
79. Khachik F, Beecher GR, Smith Jr JC. Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J Cell Biochem 1995;22:236-46.
80. Gartner S, Henkind P. Ageing and degeneration of the human macula. 1. Outer nuclear layer and photoreceptors. Br J Ophthalmol 1981;65:23-8.
81. Organisciak DT, Jiang YL, Wang HM, et al. The protective effect of ascorbic acid in retinal light damage of rats exposed to intermittent light. Invest Ophthalmol Vis Sci 1990;31:1195-202.
82. Dorey CK, Wu G, Ebenstein D, et al. Cell loss in the ageing retina. Relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci 1989;30:1691-9.
83. Ahmed J, Braun RD, Dunn R Jr, et al. Oxygen distribution in the macaque retina. Invest Ophthalmol Vis Sci 1993;34:516-21.
84. Ham WT Jr, Mueller HA, Ruffolo JJ, et al. Sensitivity of the retina to radiation damage as a function of wavelength. Photochem Photobiol 1979;29:73543.
85. Putting BJ, van Best JA, Zweypfenning RC, et al. Spectral sensitivity of the blood-retinal barrier at the pigment epithelium for blue light in the 400-500 nm range. Graefes Arch Clin Exp Ophthalmol 1993;231:600-6.
86. Rozanowska M, Jarvis-Evans J, Karytowski W, et al. Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem 1995;270:18825-30.
87. Davies S, Boulton ME. The phototoxicity of lipofuscin in vitro, Exp Eye Res (Abstract 349, S.102.) XIII International Congress of Eye Research, 1998.
88. Ishibashi T, Sorgente N, Patterson R, et al. Pathogenesis of drusen in the primate. Invest Ophthalmol Vis Sci 1986;27:184-93.
89. Ishibashi T, Patterson R, Ohnishi Y, et al. Formation of drusen in the human eye. Am J Ophthalmol 1986;101:342-53.
90. Bone RA, Landrum J, Cains A. Optical density spectra of the macular pigment in vivo and in vitro. Vis Res 1992;32:105-10.
91. Kilbride PE, Alexander KR, Fishman M, et al. Human macular pigment assessed by imaging fundus reflectometry. Vis Res 1989;29:663-74.
92. Elsner AE, Burns SA, Beausencourt E, et al. Foveal cone photopigment distribution: small alterations associated with macular pigment distribution. Invest Ophthalmol Vis Sci 1998;39:2394-404.
93. Hammond BR Jr, Fuld K, Snodderly DM. Iris colour and macular pigment optical density. Exp Eye Res 1996;62:293-7.
94. Hammond BR, Wooten BR, Snodderly DM. Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vis Res 1996;36:3003-9.
95. Hammond BR Jr, Wooten BR, Snodderly DM. Density of the human crystalline lens related to the macular pigment carotenoids, lutein and zeaxanthin. Optom Vis Sci 1997;74:499-504.
96. Van den Berg TJTP, Ijspeert JK, de Waard PWT. Dependence of intraocular stray light on pigmentation and light transmission through the ocular wall. Vis Res 1991;31:1361-7.
97. Hyman LG, Lilienfeld AM, Ferris FL III, et al. Senile macular degeneration: a case-control study. Am J Epidemiol 1983;118:213-27.
98. Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992;110:1701-8.
99. Weiter JJ, Delori FC, Wing GL, et al. Relationship of senile macular degeneration to ocular pigmentation. Am J Ophthalmol 1985;99:185-7.
100. Stock CJ, Canter LA, Puklin JE, et al. Gender, race, iris colour, and age-related maculopar degeneration. Invest Ophthalmol Vu Sci 1995; 36(Suppl), S10 (abstract).
101. Holz FG, Piguet B, Minassian DC, et al. Decreasing stromal iris pigmentation as a risk factor for age-related macular degeneration. Am J Ophthalmol 1994;117:19-23.
102. Sandberg MA, Gaudio AR, Miller S, et al. Iris pigmentation and extent of disease in patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 1994;35:2734-40.
103. Blumenkranz MS, Rusell SR, Robey MG, et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986;93:552-6.
104. Gibson JM, Shaw DE, Rosenthal AR. Senile cataract and senile macular degeneration. An investigation into possible risk-factors. Trans Ophthalmol Soc UK 1986;105:463-9.
105. West SK, Rosenthal FS, Bressler NM, et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 1989;107:875-9.
106. Menon IA, Wakeham DC, Persad SD, et al. Quantitative determination of the melanin contents of ocular tissues from human blue and brown eyes. J Ocular Pharmacol 1992;8:35-42.
107. Hyman L, He Q, Grimson R, et al. Risk-factors for age-related maculopathy. Invest Ophthalmol. Vis Sci 1992;33:801 (abstract).
108. Paetkau ME, Boyd TAS, Grace M, et al. Senile disciform macular degeneration and smoking. Can J Ophthalmol 1978;13:67-71.
109. Klein R, Klein BEK, Linton KLP, et al. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 1993;137: 190-200.
110. Vingerling JR, Dielemans I, Hofman A, et al. Age-related macular degeneration and smoking. The Rotterdam study. Invest Ophthalmol Vis Sci 1995;36(Suppl) S9 (abstract).
111. Kondo T, Tagami S, Yoshioka A, et al.Current smoking of elderly men reduces antioxidants in alveolar macrophages. Am J Resp Crit Care Med 1994;149:178-82.
112. Duthie GG, Arthur JR, James WPT. Effects of smoking and vitamin E on blood oxidant status. Am J Clin Nutr 1991;531061S-3S.
113. Mezzetti A, Lapenna D, Pierdomenico SD, et al. Vitamins E, C and lipid peroxidation is plasma and arterial tissue of smokers and non-smokers. Atherosclerosis 1995;112:91-9.
114. West S, Munoz B, Emmett EA, et al. Cigarette smoking and risk of nuclear cataract. Arch Ophthalmol 1989;107:1166-9.
115. Armstrong D, Hiramitsu T. Studies of experimentally induced retinal degeneration. 2. Early morphological changes produced by lipid peroxidation in the albino rabbit. Jap J Ophthalmol 1990;34:158-73.
116. Klein Rj Rowland ML, Harris MI. Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. Ophthalmology 1995;102:371-81.
117. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study, I: outline and major prevalence findings. Am J Epidemiol 1977;106:17-32.
118. Schachat AP, Hyman L, Leske MC, et al. and the Barbados Eye Study Group. Features of age-related macular degeneration in a black population. Arch Ophthalmol 1995;113:728-35.
119. Cruickshanks KJ, Klein R, Klein BEK. Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol 1993;111:514-18.
120. Liu IY, White L, LaCroix AZ. The association of age-related macular degeneration and lens opacities in the aged. Am J Publ Health 1989;79:765-9.
121. Hankinson SE, Willett WC, Colditz GA, et al. A prospective study of cigarette smoking and risk of cataract surgery in women. JAMA 1992;268:994-8.
122. Hiller R, Giacometti L, Yuen K. Sunlight and cataract: an epidemiologic investigation. Am J Epidemiol 1977;105:450-9.
123. Taylor HR, Wes SK, Rosenthal FS, et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med 1988;319:1429-33.
124. Leske MC, Chylack MT Jr, Wu SY. The Lens Opacities Case-Control Study Group: risk factors for cataract. Arch Ophthalmol 1991;109:244-51.
125. Jaques PF, Chylack LT Jr, McGandy RB, et al. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1988;106:337-40.
126. Yeum KJY, Taylor A, Tang G, et al. Measurement of carotenoids, retinoids and tocopherols in human lenses. Invest Ophthalmol Vis Sci 1995;36:2756-61.
127. Goldberg J, Flowerdrew G, Smith E, et al. Factors associated with age-related macular degeneration - analysis of data from NHANES I. Am J Epidemiol 1988;128:700-11.
128. Seddon JM, Ajani UA, Sperduto RD, et al for the Eye Disease Case-Control Study Group. Dietary carotenoids, vitamins A, C and E, and advance age-related macular degeneration. JAMA 1994;272:1413-20.
129. Hammond BR Jr, Wooten BR, Snodderly DM. Preservation of visual sensitivity of older subjects: association with macular pigment density. Invest Ophthalmol Vis Sci 1998;39:397-404.
130. Applegate RA, Adams AJ, Cavender JC, et al. Early color vision changes in age-related maculopathy. Appl Optics 1987;26:1455-7.
131. Eisner A, Fleming SA, Klein ML, et al. Sensitivities in older eyes with good acuity: eyes whose fellow eye has exudative AMD. Invest Ophthalmol Vis Sci 1987;28:1832-7.
132. Eisner A, Klein ML, Zilis JD, et al. Visual function and the subsequent development of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 1992;33:3091-102.
133. Krill AE, Deutman AF. Dominant macular degenerations. The cone dystrophies, Am J Ophthalmol 1972;73:352-9.
134. Pruett RC. Retinitis pigmentosa. Clinical observations and correlations. Trans Am Ophthalmol Soc 1983;81:693-700.
135. Spalton DJ, Taylor DSI, Sanders MD. Juvenile Batten's disease. An ophthalmological assessment of 26 patients. Br J Ophthalmol 1980;64:726-31.
136. Deutman AF. Benign concentric annular macular dystrophy. Am J Ophthalmol 1980;90:597-601.
137. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye 1988;2:552-77.
138. Maguire P, Vine AK. Geographic atrophy of the retinal pigment epithelium. Am J Ophthalmol 1986;102:621-5.
139. Schatz H, McDonald HR. Atrophic macular degeneration: rate of spread of geographic atrophy and visual loss. Ophthalmology 1989;96:1541-51.
140. Weiter JJ, Delori FC, Dorey CK. Central sparing in annular macular degeneration. Am J Ophthalmol 1988;106:286-90.
141. Matsumura M, Ohkuma M, Tsukahara I. Experimental chloroquine retinopathy. Ophthalmic Res 1984;18:172-6.
142. Rabb MF, Tso MOM, Fishman GA. Cone-rod dystrophy. A clinical and histopathological report. Ophthalmology 1986;93:1443-7.
143. Swan PG, Lovie-Kitchin JE. Age-related maculopathy. II: The nature of the central visual field loss. Ophthalmic Physiol Opt 1991;11:59-70.
144. Wing GL, Blanchar GC, Weiter JJ. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1978;17:601-7.
145. Weiter JJ, Delori FC, Wing GL, et al. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci 1986;27:145-51.
146. Macular Photocoagulation Study Group. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 1993;111:1189-99.
147. West S, Vitale S, Hallfrisch J, et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol 1994;112:222-7.
148. The ATBC Cancer Prevention Study Group. The alpha-tocopherol, betacarotene lung cancer prevention study: design, methods, participant characteristics, and compliance, Ann Epidemiol 1994;4:1-10.
149. Teikari JM, Laatikainen L, Virtamo J, et al. Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol 1998;76:224-9.
150. Stur M, Tittl M, Reitner A, et al. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996;37:1225-35.
151. Bendich A. The safety of β-carotene. Nutr Cancer 1988;11:207-14.
152. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.